Abstract:Background: The increasing prevalence of gestational diabetes mellitus (GDM) is concerning as women with GDM are at high risk of type 2 diabetes (T2D) later in life. The magnitude of this risk highlights the importance of early intervention to prevent the progression of GDM to T2D. Rates of postpartum screening are suboptimal, often as low as 13% in Asian countries. The lack of preventive care through structured postpartum screening in several health care systems and low public awareness are key barriers to postpartum diabetes screening. Objective: In this study, we developed a machine learning model for early prediction of postpartum T2D following routine antenatal GDM screening. The early prediction of postpartum T2D during prenatal care would enable the implementation of effective strategies for diabetes prevention interventions. To our best knowledge, this is the first study that uses machine learning for postpartum T2D risk assessment in antenatal populations of Asian origin. Methods: Prospective multiethnic data (Chinese, Malay, and Indian ethnicities) from 561 pregnancies in Singapore's most deeply phenotyped mother-offspring cohort study—Growing Up in Singapore Towards healthy Outcomes—were used for predictive modeling. The feature variables included were demographics, medical or obstetric history, physical measures, lifestyle information, and GDM diagnosis. Shapley values were combined with CatBoost tree ensembles to perform feature selection. Our game theoretical approach for predictive analytics enables population subtyping and pattern discovery for data-driven precision care. The predictive models were trained using 4 machine learning algorithms: logistic regression, support vector machine, CatBoost gradient boosting, and artificial neural network. We used 5-fold stratified cross-validation to preserve the same proportion of T2D cases in each fold. Grid search pipelines were built to evaluate the best performing hyperparameters. Results: A high performance prediction model for postpartum T2D comprising of 2 midgestation features—midpregnancy BMI after gestational weight gain and diagnosis of GDM—was developed (BMI_GDM CatBoost model: AUC=0.86, 95% CI 0.72-0.99). Prepregnancy BMI alone was inadequate in predicting postpartum T2D risk (ppBMI CatBoost model: AUC=0.62, 95% CI 0.39-0.86). A 2-hour postprandial glucose test (BMI_2hour CatBoost model: AUC=0.86, 95% CI 0.76-0.96) showed a stronger postpartum T2D risk prediction effect compared to fasting glucose test (BMI_Fasting CatBoost model: AUC=0.76, 95% CI 0.61-0.91). The BMI_GDM model was also robust when using a modified 2-point International Association of the Diabetes and Pregnancy Study Groups (IADPSG) 2018 criteria for GDM diagnosis (BMI_GDM2 CatBoost model: AUC=0.84, 95% CI 0.72-0.97). Total gestational weight gain was inversely associated with postpartum T2D outcome, independent of prepregnancy BMI and diagnosis of GDM (P=.02; OR 0.88, 95% CI 0.79-0.98). Conclusions: Midgestation weight gain effects, combined with the metabolic derangements underlying GDM during pregnancy, signal future T2D risk in Singaporean women. Further studies will be required to examine the influence of metabolic adaptations in pregnancy on postpartum maternal metabolic health outcomes. The state-of-the-art machine learning model can be leveraged as a rapid risk stratification tool during prenatal care. Trial Registration: ClinicalTrials.gov NCT01174875; https://clinicaltrials.gov/ct2/show/NCT01174875

Development And Validation Of A Clinical Model For Preconception And Early Pregnancy Risk Prediction Of Gestational Diabetes Mellitus In Nulliparous Women

A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study

976: Improved First Trimester Selective Screening for Gestational Diabetes Mellitus in Nulliparous Women

Early Prediction of High Risk Gestational Diabetes Mellitus <i>via</i> Machine Learning Models

A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus

Early Pregnancy Prediction of Gestational Diabetes Mellitus Risk Using Prenatal Screening Biomarkers in Nulliparous Women.

Protocol for development and validation of a clinical prediction model for adverse pregnancy outcomes in women with gestational diabetes

Risk Prediction Models of Gestational Diabetes Mellitus Before 16 Gestational Weeks

Early Prediction of Gestational Diabetes Mellitus in the Chinese Population Via Advanced Machine Learning

Development and validation of a risk prediction model for preterm birth in women with gestational diabetes mellitus

Clinical First-Trimester Prediction Models for Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis

Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in women with gestational diabetes: The PeRSonal GDM model

An early prediction model for gestational diabetes mellitus based on genetic variants and clinical characteristics in China

Developing and validating a predictive model of delivering large-for-gestational-age infants among women with gestational diabetes mellitus

Development and Validation of Risk Prediction Models for Gestational Diabetes Mellitus Using Four Different Methods.

Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study

An early model to predict the risk of gestational diabetes mellitus in the absence of blood examination indexes: application in primary health care centres

Machine Learning–Derived Prenatal Predictive Risk Model to Guide Intervention and Prevent the Progression of Gestational Diabetes Mellitus to Type 2 Diabetes: Prediction Model Development Study

Risk factors and prediction model for low-birth-weight infants born to women with gestational diabetes mellitus

A clinical model and nomogram for early prediction of gestational diabetes based on common maternal demographics and routine clinical parameters.

A first trimester prediction model and nomogram for gestational diabetes mellitus based on maternal clinical risk factors in a resource-poor setting